US Patent Issued to Enanta Pharmaceuticals on Oct. 6 for "Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,204, issued on Oct. 6, was assigned to Enanta Pharmaceuticals Inc. (Watertown, Mass.).

"Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof" was invented by Guoqiang Wang (Belmont, Mass.), Yat Sun Or (Waltham, Mass.), Ruichao Shen (Belmont, Mass.), Xuechao Xing (Wilmington, Mass.), Jiang Long (Wayland, Mass.), Peng Dai (Auburndale, Mass.), Brett Granger (Sudbury, Mass.) and Jing He (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds represented by Formula I, or pharmaceutically acceptable salts, stereoisomers, solvates, hydrates or combination thereof,The invention also provides...